Simulations Plus' (SLP) latest DILIsym version X has a redesigned software infrastructure that includes server/cloud computing functionalities as well as command line and graphical interface options.
The ASR is a part of earlier announced (December 2022) $50 million share repurchase plan by Simulations Plus (SLP).
Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it has entered into an accelerated share...
Simulations Plus' (SLP) Q1 results were affected by lower revenues in Software business segment.
March S&P 500 futures (ESH23) are trending down -0.07% this morning after three major U.S. benchmark indices finished higher in volatile trading on Wednesday as investors digested the release of the Federal...
Simulations Plus (SLP) delivered earnings and revenue surprises of -50% and 3.79%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus: Fiscal Q1 Earnings Snapshot
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first quarter...
Simulations Plus' (SLP) first-quarter performance is likely to gain from healthy adoption of its solutions across various verticals.